NCT04572451 2025-08-01Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and MelanomaUniversity of PittsburghPhase 1 Recruiting50 enrolled
NCT04544748 2024-03-06A Phase 1 Study of GNR-051 in Subjects With Advanced MalignanciesAO GENERIUMPhase 1 Active not recruiting48 enrolled
NCT02543645 2018-04-30A Study of Varlilumab and Atezolizumab in Patients With Advanced CancerCelldex TherapeuticsPhase 1 Terminated18 enrolled